Literature DB >> 25421069

A population-based study of the incidence and case fatality of non-aneurysmal subarachnoid hemorrhage.

Adnan I Qureshi1, Nauman Jahangir, Mushtaq H Qureshi, Archie Defillo, Ahmed A Malik, Gregory T Sherr, M Fareed K Suri.   

Abstract

BACKGROUND: There is a paucity of reliable and recent data regarding epidemiology of non-aneurysmal subarachnoid hemorrhage (SAH) in population-based studies.
OBJECTIVES: To determine the incidence and case fatality of non-aneurysmal SAH using a population-based design.
METHODS: Medical records and angiographic data of all patients from Stearns and Benton Counties, Minnesota, admitted with SAH were reviewed to identify incident case of non-aneurysmal SAH. Patients with a first-time diagnosis of non-aneurysmal SAH (based on two negative cerebral angiograms performed ≥7 days apart) between June 1st, 2012 and June 30th, 2014 were considered incident cases. We calculated the incidences of non-aneurysmal and aneurysmal SAH adjusted for age and sex based on the 2010 US census.
RESULTS: Of the 18 identified SAH among 189,093 resident populations, five were true incident cases of non-aneurysmal SAH in this population-based study. The age- and sex-adjusted incidence of non-aneurysmal SAH were 2.8 [95 % confidence interval (CI) 2.7-2·9] per 100,000 person-years which was lower than aneurysmal SAH incidence of 7.2 [95 % CI 7.1-7.4] per 100,000 person-years. The age-adjusted incidence of non-aneurysmal SAH was similar (compared with aneurysmal SAH) among men; 3.2 [95 % CI 3.1-3.3] per 100,000 person-years versus 2.2 [95 % CI 2.1-2.3] per 100,000 person-years, respectively. The age-adjusted case fatality rate at 3 months was 4.46 and 0.0 per 100,000 persons for aneurysmal and non-aneurysmal SAH, respectively.
CONCLUSIONS: The incidence of non-aneurysmal SAH was higher than previously reported particularly among men.

Entities:  

Mesh:

Year:  2015        PMID: 25421069     DOI: 10.1007/s12028-014-0084-7

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  32 in total

1.  Computed tomographic angiography versus digital subtraction angiography for the diagnosis and early treatment of ruptured intracranial aneurysms.

Authors:  G B Anderson; D E Steinke; K C Petruk; R Ashforth; J M Findlay
Journal:  Neurosurgery       Date:  1999-12       Impact factor: 4.654

2.  Subarachnoid hemorrhage patients: to transfer or not to transfer?

Authors:  Jack Rosner; Miriam Nuno; Chad Miller; David Palestrant; Wouter I Schievink; Michael J Alexander; Doniel Drazin
Journal:  Neurosurgery       Date:  2013-08       Impact factor: 4.654

3.  A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.

Authors:  E C Haley; N F Kassell; C Apperson-Hansen; M H Maile; W M Alves
Journal:  J Neurosurg       Date:  1997-03       Impact factor: 5.115

4.  Incidence of aneurysmal subarachnoid hemorrhage in Norway, 1999-2007.

Authors:  H M Lindekleiv; I Njølstad; T Ingebrigtsen; E B Mathiesen
Journal:  Acta Neurol Scand       Date:  2011-01       Impact factor: 3.209

5.  Impact of International Subarachnoid Aneurysm Trial results on treatment of ruptured intracranial aneurysms in the United States. Clinical article.

Authors:  Adnan I Qureshi; Gabriela Vazquez; Nauman Tariq; M Fareed K Suri; Kamakshi Lakshminarayan; Giuseppe Lanzino
Journal:  J Neurosurg       Date:  2010-07-23       Impact factor: 5.115

6.  Impact of a dedicated neurocritical care team in treating patients with aneurysmal subarachnoid hemorrhage.

Authors:  Owen Samuels; Adam Webb; Steve Culler; Kathleen Martin; Daniel Barrow
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

7.  Yield of further diagnostic work-up of cryptogenic subarachnoid hemorrhage based on bleeding patterns on computed tomographic scans.

Authors:  Norberto Andaluz; Mario Zuccarello
Journal:  Neurosurgery       Date:  2008-05       Impact factor: 4.654

8.  Incidence, case-fatalities and 10-year survival of subarachnoid hemorrhage in a population-based registry.

Authors:  Simona Sacco; Rocco Totaro; Danilo Toni; Carmine Marini; Davide Cerone; Antonio Carolei
Journal:  Eur Neurol       Date:  2009-07-02       Impact factor: 1.710

9.  A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.

Authors:  E C Haley; N F Kassell; J C Torner
Journal:  J Neurosurg       Date:  1993-04       Impact factor: 5.115

10.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245

View more
  4 in total

1.  A Population-Based Study of the Incidence of Acute Spinal Cord Infarction.

Authors:  Adnan I Qureshi; Mohammad Rauf Afzal; M Fareed K Suri
Journal:  J Vasc Interv Neurol       Date:  2017-06

2.  A Population-Based Study of the Incidence and Case Fatality of Intracerebral Hemorrhage of Undetermined Etiology.

Authors:  Adnan I Qureshi; Mohammad R Afzal; Ahmed A Malik; Mushtaq H Qureshi; Nauman Jahangir; M Fareed K Suri
Journal:  J Vasc Interv Neurol       Date:  2015-10

3.  Subarachnoid haemorrhage with negative initial neurovascular imaging: a systematic review and meta-analysis.

Authors:  Midhun Mohan; Abdurrahman I Islim; Fahid T Rasul; Ola Rominiyi; Ruth-Mary deSouza; Michael T C Poon; Aimun A B Jamjoom; Angelos G Kolias; Julie Woodfield; Krunal Patel; Aswin Chari; Ramez Kirollos
Journal:  Acta Neurochir (Wien)       Date:  2019-08-13       Impact factor: 2.216

4.  Subarachnoid Hemorrhage and COVID-19: An Analysis of 282,718 Patients.

Authors:  Adnan I Qureshi; William I Baskett; Wei Huang; Daniel Shyu; Danny Myers; Iryna Lobanova; Muhammad F Ishfaq; S Hasan Naqvi; Brandi R French; Farhan Siddiq; Camilo R Gomez; Chi-Ren Shyu
Journal:  World Neurosurg       Date:  2021-04-30       Impact factor: 2.104

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.